Edwards Lifesciences Corp (NYSE:EW)
$ 88.84 -1.27 (-1.41%) Market Cap: 53.53 Bil Enterprise Value: 53.31 Bil PE Ratio: 38.29 PB Ratio: 7.52 GF Score: 98/100

Q2 2019 Edwards Lifesciences Corp Earnings Call Transcript

Jul 23, 2019 / 09:00PM GMT
Release Date Price: $65.15 (+0.74%)
Operator

Greetings, and welcome to the Edwards Lifesciences' Second Quarter 2019 Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Mark Wilterding, Vice President, Investor Relations. Thank you. Please begin.

Mark Wilterding
Edwards Lifesciences Corporation - VP of IR

Thank you, Rayah. Good afternoon, and thank you for joining us today. Just after the close of regular trading, Edwards Lifesciences released its second quarter 2019 financial results. During today's call, management will discuss the results included in the press release and accompanied financial schedules and then use the remaining time for Q&A. Our presenters on today's call are Mike Mussallem, Chairman and Chief Executive Officer; and Scott Ullem, Chief Financial Officer.

Before we begin, I'd like to remind you that today's -- during today's call, management will be making forward-looking statements that are based on estimates, assumptions and projections. These statements include, but aren't

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot